ChromaDex (NASDAQ: CDXC) reported Q2 EPS of ($0.05), $0.09 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $5.31 million versus the consensus estimate of $11 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.